Search | PALTmed

Showing 1 - 10 of 92 results

Press Release

November 14, 2022

New Covid Toolkit and Webinar Will Help Keep Everyone Safe This Winter

Five major medical societies have collaborated to create a toolkit for clinicians to help increase awareness of the critical importance, effectiveness, and accessibility of the COVID-19 bivalent booster and oral anti-viral therapeutics in post-acute and long-term care settings.

Respiratory Syncytial Virus (RSV)

Explore our education, products, journal articles, and news specific to RSV in post-acute and long-term care settings.

Immunization

Explore our education, products, journal articles, and news specific to immunization in post-acute and long-term care settings.

JAMDA

April 7, 2014

New Toolkit to Measure Quality of Person-Centered Care: Development and Pilot Evaluation With Nursing Home Communities

Increasingly, nursing home (NH) providers are adopting a person-centered care (PCC) philosophy; yet, they currently lack methods to measure their progress toward this goal. Few PCC tools meet criteria for ease of use and feasibility in NHs. The purpose of this article is to report on the development of the...

Policy Snapshot

March 15, 2024

Skilled Nursing Facilities: Billing Medicare for Respiratory Vaccines

Medicare pays for vaccines administered during a patient’s stay in a nursing home. Vaccine payment depends on the type of vaccine and whether the patient is using their Skilled Nursing Facility Part A benefit. Learn how to bill for a number of vaccines

Resolutions

March 1, 2002

C02 - Influenza Vaccine Availability

Policy Snapshot

December 15, 2023

Billing for Flu, Pneumococcal, and COVID-19 Vaccines

For flu, pneumococcal, and COVID-19 vaccines furnished on or after July 1, 2023, to patients staying in a Medicare Part A-covered skilled nursing facility (SNF), immunizers can no longer bill Medicare directly.

Policy Snapshot

May 31, 2024

Morbidity and Mortality Weekly Report — Early Safety Findings Among Persons Aged 60 Years and Older Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.

Spotlight

November 2, 2023

Toolkit Helps Providers Develop Public Messaging about the Benefits of Advance Care Planning, Palliative Care, and Hospice

JAMDA

July 20, 2021

Racial Disparities in COVID-19 Vaccine Acceptance: Building Trust to Protect Nursing Home Staff and Residents

Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...